Skip to content

QUANTRX BIOMEDICAL CORP

company.status.inactive

CIK 820608fmd_1X8EWCMFR4E3C8F62YJ8BB44J8Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2010 to Sep 30, 2022, 51 periods

Latest annual · FY2020

Millions
Total revenues
0
Operating income
(0)
Net income
(0)

Latest quarter · Q3 FY2022

Millions
Operating income
(0)
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2017 to FY2020
n/m
Net income, 5 yearsFY2016 to FY2021
n/m

QUANTRX BIOMEDICAL CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Operating income-$43,383-$60,62410-K 2022-04-15 · proof
Net income-$260,042-$252,73410-K 2022-04-15 · proof
Cash from operating activities-$49,478-$74,92310-K 2022-04-15 · proof
Total assets$5,950$55,428-89.3%10-K 2022-04-15 · proof
Total liabilities$2.6 million$2.4 million+8.6%10-K 2022-04-15 · proof
Cash and cash equivalents$5,950$55,428-89.3%10-K 2022-04-15 · proof
What was QUANTRX BIOMEDICAL CORP's operating income in fiscal 2021?
QUANTRX BIOMEDICAL CORP reported operating income of -$43,383 for fiscal 2021 (the year ended Dec 31, 2021), against -$60,624 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What was QUANTRX BIOMEDICAL CORP's net income in fiscal 2021?
QUANTRX BIOMEDICAL CORP reported net income of -$260,042 for fiscal 2021 (the year ended Dec 31, 2021), against -$252,734 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What was QUANTRX BIOMEDICAL CORP's cash from operating activities in fiscal 2021?
QUANTRX BIOMEDICAL CORP reported cash from operating activities of -$49,478 for fiscal 2021 (the year ended Dec 31, 2021), against -$74,923 the year before. Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What are QUANTRX BIOMEDICAL CORP's total assets?
As of Dec 31, 2021, QUANTRX BIOMEDICAL CORP reported total assets of $5,950, against $55,428 a year earlier (-89.3%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What are QUANTRX BIOMEDICAL CORP's total liabilities?
As of Dec 31, 2021, QUANTRX BIOMEDICAL CORP reported total liabilities of $2.6 million, against $2.4 million a year earlier (+8.6%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC
What are QUANTRX BIOMEDICAL CORP's cash and cash equivalents?
As of Dec 31, 2021, QUANTRX BIOMEDICAL CORP reported cash and cash equivalents of $5,950, against $55,428 a year earlier (-89.3%). Source: the 10-K filed with the SEC on Apr 15, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:820608&period_type=annual&limit=5"

Information only, not investment advice.